Press Releases

12345678910
Easterly Government Properties to Participate in BMO Real Assets Conference
Easterly Government Properties, Inc. (NYSE: DEA), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, announced today that management will participate in investor meetings at the BMO Real Assets Conference in New York, NY beginning on May 11th, 2026.
ARIS Recognised as a Leader in Gartner® Magic Quadrant™ for Process Intelligence Platforms, Believes This Reinforces Its Role in Enabling Enterprise AI at Scale
ARIS, the process context foundation platform for enterprise AI deployment, today announced its recognition as a Leader in the Gartner® Magic Quadrant™ for Process Intelligence Platforms.
By ARIS · Via Business Wire · May 11, 2026
Kerrigan Advisors Represents Plaza Ford in Sale to Bob Bell Automotive Group
Kerrigan Advisors, the leading sell-side advisor and thought partner to auto dealers nationwide, represented the Walls Family in the sale of Plaza Ford to Bob Bell Automotive Group. The sale of the Bel Air, Maryland dealership marks Kerrigan Advisors’ 327th dealership sold since the firm’s inception and its 51st Mid-Atlantic franchise transaction. Notably, Kerrigan Advisors has transacted on the sale of more than $3 billion in dealership revenue across 13 states over the last 12 months.
By Kerrigan Advisors · Via Business Wire · May 11, 2026
SnackPro® Launches AI App to Help Families Quickly Identify Food Allergens
For millions of parents, every snack, restaurant meal or birthday party comes with the same worry: Can my child eat this?
By SnackPro · Via Business Wire · May 11, 2026
OM1 Supports 650,000 Patient Real-World Regulatory Submission for FDA Approval of Hologic's Aptima HPV Assay
OM1, a real-world evidence generation company and the leading AI outcomes platform, presented its role in the landmark study that supported FDA approval of Hologic's Aptima HPV Assay for primary cervical cancer screening at the Medical Device Innovation Consortium Evidence Summit on May 5, 2026. The approval, announced by Hologic in February 2026, followed one of the largest real-world evidence studies ever conducted for an FDA submission — spanning more than 650,000 women across multiple U.S. health systems.
By OM1 · Via Business Wire · May 11, 2026
MidOcean Partners Signs Definitive Agreement to Exit Questex
MidOcean Partners (“MidOcean” or the “Firm”), a premier New York-based alternative asset manager specializing in middle market private equity, alternative credit, and structured equity, announced today the signing of the sale of Questex, LLC (“Questex” or the “Company”) to funds managed by Apollo (NYSE: APO) (“Apollo”). Questex is a leading information services and event platform company focused on the experience economy. The Company connects buyers and sellers across industries including hospitality, travel, wellness, life sciences, and technology through its integrated portfolio of live events, digital media, and data-driven marketing services.
By MidOcean Partners · Via Business Wire · May 11, 2026
Unit21 Named Category Leader in Chartis 2026 RiskTech Quadrants® for Enterprise and Payment Fraud Solutions
Unit21, the leading AI Risk Infrastructure platform for fraud prevention and AML monitoring, today announced it has been named a Category Leader in Chartis 2026 RiskTech Quadrants® for Enterprise Fraud Solutions and Payment Fraud Solutions. Across the evaluation, Unit21 received the highest score across all vendors evaluated for AI functionality—formal validation of the company’s strategic emphasis on agentic AI as the underlying infrastructure of fraud and AML operations, not as an experimental add-on.
By Unit21 · Via Business Wire · May 11, 2026
Ankyra Therapeutics Announces Preclinical Presentation of Anchored Immunotherapy Using Monoclonal Antibodies at PEGS Boston 2026
Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored immunotherapy to deliver better outcomes for people with cancer and other serious diseases, announced a poster presentation will be featured at the 2026 PEGS Boston Summit, taking place May 11-15 in Boston.
By Ankyra Therapeutics · Via Business Wire · May 11, 2026
GCI Liberty Provides Update Following Discussions with Chairman John Malone
GCI Liberty, Inc. (“GCI Liberty”) today announced that, following unexpected obstacles to completing a larger, more strategic transaction relating to Liberty Latin America Ltd. (“LLA”), Chairman of the Board, Dr. John C. Malone has determined to terminate discussions with GCI Liberty regarding any further acquisitions of his LLA interests and has offered to acquire GCI Liberty’s 6% equity interest in LLA at the same price paid by GCI Liberty last month. The Board of Directors has accepted this offer.
By GCI Liberty, Inc. · Via Business Wire · May 11, 2026
Forge Biologics Announces Seven Presentations at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
Forge Biologics, (“Forge”), a leading manufacturer of gene therapies and member of the Ajinomoto Bio-Pharma Services group, today announced that it will deliver seven presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting, taking place May 11-15, 2026, in Boston. The presentations include two technical sessions, co-chairing an oral abstract session, and four scientific posters.
By Forge Biologics · Via Business Wire · May 11, 2026
365 Retail Markets Completes Acquisition of Cantaloupe to Expand Technology Capabilities and Customer Value
365 Retail Markets, LLC (“365”), a leading innovator in unattended retail technologies, today announced that it has completed its acquisition of Cantaloupe, Inc. (“Cantaloupe”), a global technology leader offering end-to-end technology solutions for self-service commerce. 365 is a portfolio company of Providence Equity Partners L.L.C. (“Providence”), a specialist private equity investment firm focused on growth-oriented media, communications and education companies across North America and Europe.
CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia
CEL-SCI Corporation (NYSE American: CVM) today announced it has signed a strategic partnership, distribution, and revenue sharing agreement with Amarox for regulatory affairs, marketing and potential commercialization of *Multikine® (Leukocyte Interleukin, Injection) in the treatment of head and neck cancer in Saudi Arabia, with an optional extension for the Gulf Cooperation Council (GCC) countries including Bahrain, Kuwait, Oman, Qatar, and the United Arab Emirates.
By CEL-SCI Corporation · Via Business Wire · May 11, 2026
Wall Street Has Its Bull. HilltopSecurities Has Its Buffalo.
Hilltop Securities Inc. (“HilltopSecurities”), one of the nation’s leading full-service investment banks and a wholly owned subsidiary of Hilltop Holdings Inc. (NYSE: HTH), today announced that its 80th anniversary campaign is now appearing on a digital video board in Times Square. The placement, at 46th Street and Broadway, runs through summer.
By Hilltop Securities Inc. · Via Business Wire · May 11, 2026
The Vitamin Shoppe to Add Shakeology by BODi in Retail Locations Nationwide
BODi (NASDAQ: BODI), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, today announced that its premium protein and superfood nutrition solution, Shakeology®, will launch in The Vitamin Shoppe nationwide later this year, significantly expanding access to one of the most successful brands in the nutrition category. The launch into The Vitamin Shoppe, which has over 640 locations, builds on Shakeology’s entry into retail, with the product launching soon in more than 80 Sprouts Farmers Market locations across the U.S.
By BODi · Via Business Wire · May 11, 2026
Lumentum Joins the Nasdaq-100 Index®, Achieving New Milestone in Global Growth
Lumentum Holdings Inc. ("Lumentum"), a leading designer and manufacturer of innovative optical and photonic products, today announced its inclusion in the Nasdaq-100 Index®, marking a significant milestone in its journey over the past year. The company is expected to join the index prior to market open on Monday, May 18, 2026.
By Lumentum · Via Business Wire · May 11, 2026
Abry Private Debt Acquires $330 Million Private Credit Portfolio
Abry Private Debt, the private credit strategy of Abry Partners, today announced the closing of its acquisition of a $330 million diversified private credit portfolio. Abry partnered with Coller Capital, a leading secondaries platform, to complete this transaction.
By Abry Partners · Via Business Wire · May 11, 2026
Claritev Corporation Announces Participation in BofA Securities Global Health Care Conference 2026
Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will meet with investors and host a presentation at the BofA Securities 2026 Global Health Care Conference in Las Vegas. The Company will webcast its presentation scheduled for 5:00 pm PT on Wednesday, May 13, 2026.
By Claritev Corporation · Via Business Wire · May 11, 2026
Media Advisory: Surescripts to Highlight Smarter Health Intelligence Sharing That Helps Close Gaps in Patient Care at AHIP 2026
Surescripts®, the nation’s leading health intelligence network, will present at AHIP 2026, taking place June 9–10, in Las Vegas, Nevada.
By Surescripts · Via Business Wire · May 11, 2026
U.S. Grandmaster Hans Niemann Wins Super Rapid & Blitz Poland; Claims First Leg of 2026 Grand Chess Tour
The first leg of the 2026 Grand Chess Tour (GCT) concluded in Warsaw as American Grandmaster (GM) Hans Niemann, competing in his first GCT appearance as a wildcard player, captured victory at Super Rapid & Blitz Poland with a standout performance against one of the strongest fields in international chess.
By Grand Chess Tour · Via Business Wire · May 11, 2026
Zero Latency Deploys Red Hat AI Factory with NVIDIA for Distributed Neocloud Network
Red Hat, the world's leading provider of open source solutions, today announced that Zero Latency (0.lat), a distributed AI inference network, has adopted Red Hat AI Factory with NVIDIA as the enterprise Kubernetes foundation for its U.S.-wide network. Built on Red Hat AI Factory with NVIDIA, Zero Latency’s neocloud solution aggregates, networks and dispatches AI inference from its decentralized edge datacenters into industrial centers. Its network, Zerogrid, is powered by scalable low-latency nodes of NVIDIA Blackwell GPUs.
By Red Hat, Inc. · Via Business Wire · May 11, 2026
Applebee’s Brings Back All You Can Eat with Boneless Wings, Riblets & Double Crunch Shrimp for Only $15.99
Applebee’s All You Can Eat is back! Now for a limited time this summer, guests can enjoy an unlimited American feast of Applebee’s savory Boneless Wings, Riblets & Double Crunch Shrimp – served with endless fries – for only $15.99, when dining in.* But that’s not all, guests are invited to an Applebee’s “pool party” all summer long with two NEW Poolio with Don Julio margaritas – served in a collectible Poolio cup!**
By Applebee’s · Via Business Wire · May 11, 2026
Sunscore Launches on Redfin to Show Homebuyers How Much Sunlight a Home Gets
Redfin (redfin.com), the real estate brokerage powered by Rocket, today launched Sunscore, a property-level score that tells home searchers exactly how much natural light a home receives from 0-100. The launch marks an exclusive U.S. partnership with the developer of Sunscore, Shadowmap, which provides a global interactive 3D map for sun-path visualization, shadow analysis and solar planning.
By Redfin · Via Business Wire · May 11, 2026
Countable Labs Addresses Critical Measurement Gaps in Cell and Gene Therapy
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced specialized assay services helping cell and gene therapy (CGT) developers and manufacturers understand and validate Countable Labs’ solutions to accelerate adoption of Countable PCR technology. The news comes at the American Society of Gene+Cell Therapy (ASGCT) meeting taking place May 11-15, 2026, in Boston, Mass., where the company and its collaborators will be presenting their successes in using Countable PCR technology for single-molecule counting to eliminate variability in CGT workflows. The company will also launch its “Count What Counts” grant program, giving one lucky scientist or researcher access to a free Countable PCR CGT pilot study.
By Countable Labs · Via Business Wire · May 11, 2026
Iambic to Participate in Upcoming Investor Conferences
Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced its participation in upcoming investor conferences:
By Iambic · Via Business Wire · May 11, 2026
Voyager and Red Hat Propel Red Hat Enterprise Linux into Orbit with Space Edge Micro Datacenters
Red Hat, the world’s leading provider of open source solutions, and Voyager Technologies (NYSE: VOYG) today announced the successful deployment of Red Hat Enterprise Linux 10.1 and Red Hat Universal Base Image (UBI) to Voyager’s LEOcloud Space Edge™ IaaS Micro Datacenter aboard the International Space Station (ISS). This collaboration extends a container-optimized, enterprise Linux platform into orbit, providing a more consistent and hardened operating foundation for AI-ready workloads to run in space. The milestone advances the evolution of space-based cloud services and orbital data centers (ODCs), delivering a security-enhanced operating foundation for real-time processing at the edge.
By Red Hat, Inc. · Via Business Wire · May 11, 2026
Avenacy Announces Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection in the U.S. Market
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Tranexamic Acid in 0.7% Sodium Chloride Injection in the United States. The product contains the same active ingredient as CYKLOKAPRON®, as approved by the U.S. Food and Drug Administration, and is indicated for use in patients with hemophilia for short-term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. Each vial of Tranexamic Acid in 0.7% Sodium Chloride Injection contains 1,000 mg per 100 mL (10 mg per mL) and is available as a carton of 10 single-dose ready-to-use vials.
By Avenacy · Via Business Wire · May 11, 2026
Red Hat and Sopra Steria Advance Sovereign AI Capabilities Through Expanded Collaboration
Red Hat, the world's leading provider of open source solutions, today announced a significant expansion of its long-standing collaboration with Sopra Steria, a major player in the European tech sector, to help accelerate sovereign AI initiatives. By standardizing on Red Hat OpenShift, Sopra Steria is providing an architectural blueprint and execution scale to help organizations deploy AI with technical independence across a wide range of cloud environments.
By Red Hat, Inc. · Via Business Wire · May 11, 2026
Charles Schwab Employees Mobilize to Support Local Communities During Volunteer Week
Charles Schwab once again brought employees together across the country for its annual Schwab Volunteer Week, a long-standing initiative dedicated to supporting local communities. This year’s effort engaged more than 8,500 employees in more than 10,000 volunteer opportunities and served 350 nonprofits nationwide.
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow
Charles River Laboratories International, Inc. (NYSE: CRL) today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly accelerates study timelines, and enhances pathologist efficiency, and supports the reduction of animal use in nonclinical research where scientifically appropriate.
Vontier’s Driivz Partners to Scale Duracell E-Charge Ultra-Fast Network Across the UK
Driivz, a Vontier (NYSE: VNT) company and leading global software supplier to EV charging operators and service providers, today announced a partnership to power and scale the Duracell E-Charge ultra-fast EV charging network across the UK.
By Driivz · Via Business Wire · May 11, 2026
HistoSonics Moves to Advance Additional Histotripsy Applications Announcing FDA Submission for Kidney Tumors
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced it has submitted a De Novo request to the U.S. Food and Drug Administration seeking authorization to expand the use of its Edison® Histotripsy System to include the destruction of kidney (renal) tumors.
By HistoSonics · Via Business Wire · May 11, 2026
EUROCONTROL Scales Air Traffic Innovation and Digital Sovereignty with Red Hat
Red Hat, the world's leading provider of open source solutions, today announced it is helping EUROCONTROL deliver a unified digital platform to enhance organizational resilience and accelerate innovation in air traffic management.
By Red Hat, Inc. · Via Business Wire · May 11, 2026
Red Hat and Core42 Set the Standard for Sovereign AI Infrastructure
Red Hat, the world's leading provider of open source solutions, today announced a collaboration with Core42, a G42 company and a leading provider of sovereign cloud and AI infrastructure, to architect and deliver sovereign cloud and AI services for the public sector, defense and other regulated industries across the UAE. The collaboration, formally unveiled on stage at Red Hat Summit, emphasizes Red Hat’s open hybrid cloud technologies that support Core42’s sovereign-by-design infrastructure, and enable organizations to move experimental AI pilots into production-scale environments while maintaining jurisdictional control, compliance and operational resilience.
By Red Hat, Inc. · Via Business Wire · May 11, 2026
Atlanta Braves Holdings Reports First Quarter 2026 Financial Results
Atlanta Braves Holdings, Inc. (“ABH”) (Nasdaq: BATRA, BATRK) today reported results for its first quarter 2026 results.
Calera Capital Appoints Michael O'Brien as Managing Director and Head of Business Development
Calera Capital (“Calera”), a leading middle-market private equity firm, today announced the appointment of Michael W. O'Brien as Managing Director and Head of Business Development. In this role, Mr. O'Brien will leverage his 15-plus years of direct private equity experience, extensive network, and origination capabilities to build on Calera’s existing strong deal generation capabilities.
By Calera Capital · Via Business Wire · May 11, 2026
NASA’s Jet Propulsion Laboratory Advances Deep Space Mission Operations with Red Hat OpenShift Virtualization
Red Hat, the world’s leading provider of open source solutions, today announced that NASA’s Jet Propulsion Laboratory (JPL) has migrated to Red Hat OpenShift Virtualization for its mission-critical IT infrastructure.
By Red Hat, Inc. · Via Business Wire · May 11, 2026
Take-Two Interactive Software, Inc. to Present at the TD Cowen 54th Annual Technology, Media & Telecom Conference
Take-Two Interactive Software, Inc. (NASDAQ: TTWO) today announced that Strauss Zelnick, the Company’s Chairman and Chief Executive Officer, plans to participate in a Fireside Chat at the TD Cowen 54th Annual Technology, Media & Telecom Conference. The Company’s presentation is scheduled for Wednesday, May 27, 2026 at 10:15 a.m. Eastern Time. A link to the live webcast of the presentation will be available via the Company’s website at http://take2games.com/ir. A replay of the presentation will be archived and available at the same location.
By Take-Two Interactive · Via Business Wire · May 11, 2026
Nissan and Red Hat Co-Engineer the Future of Software-Defined Vehicles
Red Hat, Inc., the world’s leading provider of open source solutions, today announced a landmark engineering initiative with Nissan Motor Co., Ltd. to build its next-generation software-defined vehicle (SDV) platform. This collaboration would involve Red Hat In-Vehicle Operating System to provide a standardized, scalable Linux foundation for Nissan Scalable Open Software Platform (SW PF), accelerating Nissan's transition toward flexible, software-defined mobility architectures.
By Red Hat, Inc. · Via Business Wire · May 11, 2026
Logistics Reply Named a Visionary in 2026 Gartner® Magic Quadrant™ for Warehouse Management Systems and Ranks #2 for Level 2 and #3 for Level 3 Operations Use Cases in Gartner® Critical Capabilities Report
Logistics Reply, the Reply Group company specializing in innovative solutions for supply chain execution, is proud to announce its recognition as a Visionary in the Gartner® Magic Quadrant™ for Warehouse Management Systems for the seventh consecutive year, as its global team of warehouse technology professionals continues to drive innovation that puts customers first. Additionally, Logistics Reply for its LEA Reply™ WMS is recognized in the 2026 Gartner® Critical Capabilities for Warehouse Management Systems report where it ranked #2 for Level 2 Warehouse Operations and #3 for Level 3 Warehouse Operations.
By Reply · Via Business Wire · May 11, 2026
AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases
Collaboration brings AGC Biologics’ advanced therapy expertise and global footprint to OTXL’s network, supporting a sustainable path from clinical development to commercial access for therapies serving the smallest patient populations
By AGC Biologics, Inc. · Via GlobeNewswire · May 11, 2026
AmeriGas Partners, L.P. and AmeriGas Finance Corp. Commence Senior Notes Offering
UGI Corporation (NYSE: UGI) announced today that its subsidiaries, AmeriGas Partners, L.P. (“AmeriGas Partners”) and AmeriGas Finance Corp. (together with AmeriGas Partners, the “Issuers”), intend to offer, subject to market and other conditions, $500,000,000 in aggregate principal amount of senior notes due 2031 (the “Notes”) in an offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States in compliance with Regulation S under the Securities Act.
By UGI Corporation · Via Business Wire · May 11, 2026
AmeriGas Partners, L.P. and AmeriGas Finance Corp. Commence Cash Tender Offers for their 5.750% Senior Notes due 2027 and 9.375% Senior Notes due 2028
UGI Corporation (NYSE: UGI) announced today that its subsidiaries, AmeriGas Partners, L.P. (“AmeriGas Partners”) and AmeriGas Finance Corp., (together with AmeriGas Partners, the “Offerors”) have commenced offers to purchase for cash (i) any and all of the Offerors’ outstanding 5.750% Senior Notes due 2027 (the “2027 Notes”) upon the terms and subject to the conditions set forth in the Offer to Purchase related to the 2027 Notes, dated May 11, 2026, and the related Letter of Transmittal and Notice of Guaranteed Delivery (the “2027 Notes Tender Offer”), and (ii) up to $175,000,000 (the “Tender Cap”) of the Offerors’ outstanding 9.375% Senior Notes due 2028 (the “2028 Notes” and, together with the 2027 Notes, the “Notes”) upon the terms and subject to the conditions set forth in the Offer to Purchase related to the 2028 Notes, dated May 11, 2026 (the “2028 Notes Tender Offer” and together with the 2027 Notes Tender Offer, the “Tender Offers”).
By UGI Corporation · Via Business Wire · May 11, 2026
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced presentations at several upcoming scientific conferences, highlighting continued progress in the application of its Axiomer RNA editing platform.
By ProQR Therapeutics N.V. · Via GlobeNewswire · May 11, 2026
Boost Run (“BRUN”) Begins Trading on Nasdaq with $940 Million of Contracted Customer Revenue
NORTHBROOK, Ill., May 11, 2026 (GLOBE NEWSWIRE) -- Boost Run, Inc. (Nasdaq: BRUN), an NVIDIA Preferred Cloud Partner operating in adherence with NVIDIA Reference Architecture standards, today provided an operational and financial update reflecting continued commercial momentum, expanding deployment capacity and disciplined execution.
By Boost Run Inc · Via GlobeNewswire · May 11, 2026
Pasqal Selected as Finalist in XPRIZE Quantum Applications Competition
PARIS, May 11, 2026 (GLOBE NEWSWIRE) -- Pasqal, a global leader in neutral-atom quantum computing, today announced that it has been selected as a finalist in the XPRIZE Quantum Applications competition for its work toward reaching quantum advantage. Pasqal recently announced plans to go public through a business combination with Bleichroeder Acquisition Corp. II.
By Pasqal Holding SAS · Via GlobeNewswire · May 11, 2026
Uniti Group Inc. Reports First Quarter 2026 Results
Reiterates Full Year 2026 Outlook
By Uniti Group Inc. · Via GlobeNewswire · May 11, 2026
Exagen Inc. Reports First Quarter 2026 Results
Delivers record total revenue and AVISE(R) CTD average selling price
By Exagen Inc. · Via GlobeNewswire · May 11, 2026
VoltaGrid Announces $1 Billion Strategic Equity Investment from Blackstone and Halliburton to Fund Growth and Acquisition of Propell
Investment to Accelerate Buildout of Behind-the-Meter Power Generation Platform for AI Data Centers
By VoltaGrid LLC · Via GlobeNewswire · May 11, 2026
Aspen Group, Inc. Amends and Extends Debt Agreement
Maturity Date Extended by One Year to May 2027Quarterly Principal Amortization Payment Reduced
By Aspen Group Inc. · Via GlobeNewswire · May 11, 2026
Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference
SOUTH SAN FRANCISCO, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that Anuj Gaggar, MD, PhD, chief medical officer, will present during the Bank of America Securities 2026 Global Health Care Conference at 4:35 p.m. Pacific Time on May 13, 2026.
By Assembly Biosciences, Inc. · Via GlobeNewswire · May 11, 2026